Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetic profiles of two Albendazole tablet
formulations manufactured under the different granulation processes in healthy Chinese adult
males.